Current advances in the clinical development of anti-tubercular agents-Reference-Cited by-同舟云学术

Current advances in the clinical development of anti-tubercular agents

Published:2020-12 Issue: Volume:125 Page:101989
ISSN:1472-9792
Container-title:Tuberculosis
language:en
Short-container-title:Tuberculosis

Author:

Tetali Samanvai Reddy,Kunapaeddi Eswar,Mailavaram Raghu Prasad,Singh Vinayak,Borah Pobitra,Deb Pran Kishore^ORCID,Venugopala Katharigatta N.^ORCID,Hourani Wafa,Tekade Rakesh Kumar

Funder

South African Medical Research Council

SAMRC

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference104 articles.

1. Global tuberculosis report 2019;World Health Organization,2019

2. The ongoing challenge of latent tuberculosis;Esmail;Philos Trans R Soc B Biol Sci,2014

3. Drug-resistance in Mycobacterium tuberculosis: where we stand;Mabhula;MedChemComm,2019

4. Global tuberculosis control: lessons learnt and future prospects;Lienhardt;Nat Rev Microbiol,2012

5. Chemotherapy of pulmonary tuberculosis in young adults;Daniels;Br Med J,1952

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and structural elucidation of novel quaternary pyridinium salt and indolizine derivatives as an anti-tubercular agent: In Silico and In Vitro screening;Journal of Molecular Structure;2025-02

2. Design, synthesis and docking studies of new molecular hybrids bearing benzimidazole and thiazolidine-2,4-dione as potential antitubercular agents;Journal of the Indian Chemical Society;2024-10

3. Investigating the potential of DL25 Compound as a Novel Anti-Mycobacterial tuberculosis Agent: A comprehensive In Silico and In Vitro Analysis;2024-09-11

4. Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies;International Journal of Biological Macromolecules;2024-08

5. Synthesis, biological activity and in silico study of alkyl eugenol derivatives as Mycobacterium tuberculosis inhibitors;Chemical Physics Impact;2024-06